SCHEMBL13845935

SCHEMBL13845935

COCCCCC/C=C/c1cc(I)ccc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
NFE2L2 Q16236 2/20 0.36
CYP1A2 P05177 1/20 0.36
BACE1 P56817 1/20 0.35
AR P10275 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
JUN P05412 1/20 0.33
NFKB1 P19838 1/20 0.33
EPHX2 P34913 1/20 0.33
REN P00797 1/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PRSS1 P07477 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13845936 0.99 CYP1A1 (0.36) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL13845930 0.96 CYP1A1 (0.36) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL7991255 0.84 L3MBTL4 (0.41) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL13846066 0.83 L3MBTL4 (0.45) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL7990539 0.82 L3MBTL4 (0.42) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL13846057 0.82 L3MBTL4 (0.43) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL13846061 0.80 NPSR1 (0.35) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL13845995 0.80 REN (0.33) CYP1A1CYP1B1NFE2L2CYP1A2AR
SCHEMBL13845993 0.80 BACE1 (0.35) CYP1A1CYP1B1NFE2L2CYP1A2BACE1
SCHEMBL8001694 0.79 L3MBTL4 (0.42) CYP1A1CYP1B1NFE2L2CYP1A2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009064955-A1 MACROCYCLIC TETRAZOLYL HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-05-22 WO disclosed